In an effort to guarantee "the ongoing quality, safety, nutritional adequacy, and resilience of the domestic infant formula ...
21h
GlobalData on MSNFDA approves Johnson & Johnson’s Tremfya to treat Crohn’s diseaseJohnson & Johnson (J&J) has received US Food and Drug Administration (FDA) approval for its interleukin 23 inhibitor, Tremfya ...
Every week for Foodie Friday, we talk in-studio with the businesspeople and culinary artisans behind outstanding La Crosse-area restaurants, bakeries, cafes, bars, food trucks, and more.
Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio.
Exclusive new testing by Consumer Reports highlights safer formulas while also identifying some that contain potentially ...
9h
Tasting Table on MSNThe Difference Between Low, Light, And Reduced Labels At The Grocery StoreSee through all the confusing labels at the grocery store. This guide to terms like low, light, and reduced will make your ...
THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...
Dermatologists are increasingly prescribing minoxidil in low-dose pills to help men and women regrow hair. The practice ...
19h
GlobalData on MSNiOnctura doses first subject in Phase II uveal melanoma treatment trialOnctura has dosed the first subject in the open-label Phase II OCULE-01 trial of oral roginolisib in individuals with rare ...
ALDI recalled over 4,800 packets of its Happy Farms cheese in Connecticut, Michigan, Ohio, and Pennsylvania due to possible ...
Lifespan is outpacing the number of years people live in good health. Scientists are developing ways of preventing illness and slowing the aging process ...
12h
Pharmaceutical Technology on MSNAlnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drugAmvuttra is now approved in the US to treat both cardiomyopathy and polyneuropathy manifestations of ATTR amyloidosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results